KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Total Liabilities: 2009-2025

Historic Total Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $4.1 billion.

  • Charles River Laboratories International's Total Liabilities fell 2.71% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year decrease of 2.71%. This contributed to the annual value of $4.0 billion for FY2024, which is 11.37% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Total Liabilities is $4.1 billion, which was down 2.35% from $4.2 billion recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Total Liabilities peaked at $4.8 billion during Q2 2022, and registered a low of $3.6 billion during Q1 2021.
  • In the last 3 years, Charles River Laboratories International's Total Liabilities had a median value of $4.3 billion in 2023 and averaged $4.3 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 39.72% in 2021, then fell by 11.37% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Total Liabilities stood at $4.4 billion in 2021, then rose by 3.32% to $4.6 billion in 2022, then fell by 0.94% to $4.5 billion in 2023, then dropped by 11.37% to $4.0 billion in 2024, then fell by 2.71% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q3 2025, $4.2 billion for Q2 2025, and $4.3 billion during Q1 2025.